Forced diuresis

Last updated on: 10.02.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Synonyms

Toxin elimination; elimination process;

Definition

Forced diuresis is the increase in excretion of toxic substances that are eliminated renally by a drug-induced increase in urine volume (Marx 2015).

General informationThis section has been translated automatically.

Implementation

After insertion of a bladder catheter, various forms of forced diuresis can be used:

  • 1. loop diuretics:

The patient receives every 4 hours:

- 1 l NaCl 0.9 % for hyperhydration

plus

- 40 mg furosemide (Herold 2022), Kasper (2015) recommends 20 - 80 mg i. v. in increasing dosage.

This is done under constant control of diuresis and water or electrolyte balance (Herold 2022).

  • 2. mannitol:

In another form of forced diuresis, the patient receives mannitol, an osmotically active diuretic. Mannitol is infused 0.25 - 1 g / kg i. v. over 20 min, and this is repeated every 4 - 6 h. The advantage of mannitol administration is a non-acidic urine (Klauwer 2013).

  • RenalGuard System:

The RenalGuard system achieves a high urine output with simultaneous euvolemia.

Here, urine is collected in a bag that is suspended from a digital scale. The scale, in turn, is connected to a high-volume fluid pump. Every drop of urine that enters the bag is replaced with NaCl by the fluid pump.

Initially, a small fluid bolus of about 3 ml / kg bw is infused, and diuresis is initiated with low doses of furosemide (0.25 mg / kg bw). As a result, urine output increases to 500 - 600 ml / min in about 60 min and can usually be maintained for 6 h without additional diuretic administration (Solomon 2014).

Note(s)This section has been translated automatically.

Pharmacodynamics

- Contrast Agent:

Forced diuresis accelerates tubule passage, thereby shortening the contact time of the contrast agent (Latus 2020).

- Loop diuretics:

Loop diuretics decrease tubular reabsorption (Michels 2010).

- Mannitol:

Mannitol is one of the osmotically active diuretics. These are glomerularly filtered but not reabsorbed in the tubules. This allows water to be osmotically bound in the tubule. Na+- excretion is low in this case (Freissmuth 2012).

In addition, mannitol can bind water intravascularly, which is required, for example, to decongest cerebral edema (Dellas 2018).

- Increase in diuresis:

If there is a pH-dependent dissociation in the elimination of toxins, acidification or alkalinization of the urine can further increase the effectiveness of diuresis (Füllgraff 2007).

Indication

Loop diuretics:

- To prevent contrast-induced kidney injury (AKI) caused by iodine-containing contrast media used in, for example, cardiac catheterization, computed tomography, etc.. Forced diuresis should begin at least 12 h before the examination and end no earlier than 12 h after the examination (Latus 2020).

- For flushing out ureteral stones (Wilhelm 2017).

- Hypercalcemia (indicated exclusively for mild hypercalcemia, as the effect is small [Kasper 2015]).

Indications for forced diuresis for secondary toxin elimination are severe intoxications with toxins to be excreted renally such as:

- Barbiturates, phenobarbital

- lithium

- salicylates such as ASS

- Thallium (Herold 2022)

mannitol:

- During chemotherapy with e.g. cisplatin, to avoid kidney damage (Kasper 2015)

- in case of poisoning (Freismuth 2012)

- In patients with e.g. arterial hypertension and pre-existing renal damage etc. (Crona 2017).

Mannitol is also used for emergency treatment of

- acute glaucoma

- acute cerebral edema (Freissmuth 2012), as it can bind water intravascularly (Dellas 2018).

RenalGuard System:

This is primarily used to prevent renal damage from iodine-containing contrast administration (Solomon 2014). It attenuates contrast-induced nephropathies (CIN) from 18% (with forced diuresis with NaCl and furosemide, see above) to 4.6% (Latus 2020) according to the MYTHOS- study from 2012 (Marenzi 2012).

Adverse effects

Loop diuretics:

There is a risk of disturbance of water, electrolyte, base, and acid balance (Herold 2022).

Mannitol:

- Volume expansion

- Hyponatremia

- Hypoosmolarity

- Headache

- Dizziness

- nausea / vomiting

- Cardiac decompensation with volume expansion (Freissmuth 2012

Contraindication

NaCl:

- heart failure

- renal insufficiency

- seizure disorder

- Shock state (Herold 2022)

Mannitol:

- myocardial insufficiency

- pulmonary edema

- Anuria (Dellas 2018)

LiteratureThis section has been translated automatically.

  1. Crona D J, Faso A, Nishijima T F, McGraw K A, Galsky M D, Milowsky M I (2017) A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity. The Oncologist 22 (5) 609 - 619
  2. Dellas C (2018) Last minute pharmacology. Elsevier Urban and Fischer Publishers Munich 55
  3. Freissmuth M, Offermanns S, Böhm S (2012) Pharmacology and toxicology: from molecular basis to pharmacotherapy. Springer Verlag Berlin / Heidelberg 368
  4. Füllgraff G, Brune K, Palm D (2007) Pharmacotherapy: clinical pharmacology. Springer Verlag Berlin / Heidelberg 525
  5. Herold G et al (2022) Internal medicine. Herold Publishers 940
  6. Kasper D L, Fauci A S, Hauser S L, Longo D L, Jameson J L, Loscalzo J et al (2015) Harrison's Principles of Internal Medicine. Mc Graw Hill Education 102e- 12, 610, 1809, 2480, 2481, 472e- 3.
  7. Klauwer D, Neuhäuser C, Thul J, Zimmermann R (2013) Pediatric intensive care pediatric cardiology practice. Deutscher Ärzteverlag GmbH 105
  8. Latus J, Schwenger V, Schlieper G, Reinecke H, Hoyer J, Persson P B, Remppis B A, Mahfoud F (2020) Contrast-induced acute kidney injury-consensus paper of the working group "Heart - Kidney" of the German Society of Cardiology - Cardiovascular Research e. V. and the German Society of Nephrology e. V. Der Kardiologe (14) 494 - 504.
  9. Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli A L (2012) Prevention of Contrast Nephropathy by Furosemide With Matched Hydration: The MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) Trial. JACC: Cardiovascular Interventions 5 (1) 90 - 97
  10. Marx G, Muhl E, Zacharowski K, Zeuzem S (2015) Critical care medicine. Springer Verlag Berlin 1319
  11. Michels G, Kochanek M (2010) Repetitorium of internal intensive care medicine. Springer Verlag Berlin / Heidelberg 105
  12. Solomon R (2014) Forced diuresis with the RenalGuard system: impact on contrast-induced acute kidney injury. J Cardiol. 63 (1) 9 - 13
  13. Wilhelm K (2017) Forced diuresis for acute ureteric colic. Urologist A. 56 (11) 1461 - 1464

Last updated on: 10.02.2023